Long-term Real-world Efficacy and Safety of Baricitinib in Alopecia Areata, Totalis, and Universalis: A Retrospective Single‑center Cohort of 330 Patients with Trichoscopy Monitoring
Published: 18 June 2026| Version 3 | DOI: 10.17632/pncfgv27c5.3
Contributors:
, , Description
Baricitinib in Alopecia Areata, Totalis, and Universalis
Files
Institutions
- West China Hospital of Sichuan UniversitySichuan, Chengdu
Categories
Alopecia Areata, Real-World Knowledge